The four metrics that institutional biotech funds actually use, the three red flags that kill deals at Series A, and how to verify a founder's claims without relying on the pitch deck.
Astroscale, ClearSpace, Starfish Space, and D-Orbit are turning orbital cleanup into a commercial market. With $1.35B projected for 2026, FCC deorbit mandates, and the first robotic capture missions moving past demonstration, the sector is crossing from government contracts into real revenue.
The Munich-based drone maker raised $1.2 billion at an $8 billion valuation, backed by Blackstone and Airbus, and is already profitable — a rarity in defense tech.
MGX, the Abu Dhabi investment firm backed by Mubadala and G42, has closed Fund I at $49 billion — above target — with a portfolio spanning OpenAI, Anthropic, xAI, and $40 billion in data centre infrastructure.
The satellite startup that bet against the small-satellite orthodoxy and won $500M+ in Pentagon and commercial contracts before its first operational delivery.
Isomorphic Labs raised $2.1B to scale its IsoDDE AI drug design engine toward first-in-human clinical trials by end of 2026.
Military UGVs are transitioning from prototype experiments to production programs. This Radar examines the platforms, programs, and procurement trends reshaping land warfare.
The combined capital expenditure tracked across 45 companies reached $941.5 billion as of July 2026, with $399.5 billion directly attributable to AI. The Big Four account for $580 billion of the total.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
